SUBSTANCE SPECIFIC TO HUMAN PD-1

摘要

CONSTITUTION: To provide an anti-human PD-1 monoclonal antibody produced from hybridoma identified with international accession number FERM BP-8392.EFFECT: The present invention provides an anti-human PD-1 monoclonal antibody produced from a hybridoma identified with international accession number FERM BP-8392. Since the anti-human PD-1 monoclonal antibody can selectively recognize human PD-1 and a membrane protein on the cell membrane of human PD-1-expressing cells and can transmit inhibitory signals of human PD-1, it is useful for therapy and/or prevention of diseases caused by immunopathy.SELECTED DRAWING: None